Higher SaFETy Scores ID Increased Prevalence of Firearm Violence
By Elana Gotkine HealthDay Reporter
MONDAY, April 22, 2024 -- The SaFETy score, a clinical screening tool specific to firearm violence, can identify young adults with past six-month firearm violence, according to a research letter published online April 23 in the Annals of Internal Medicine.
Jason E. Goldstick, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the association between the 10-point SaFETy score and past six-month self-reported firearm violence among young adults, aged 18 to 24 years, presenting to emergency departments in three cities.
A total of 1,506 young adults were enrolled; 1,483 had data on past six-month firearm violence, and 5.9 percent reported positively. The researchers found that the mean SaFETy scores were 4.7 and 0.9 for those with and without past six-month firearm violence, respectively. Those with SaFETy scores of 0, 1 to 5, and 6+ had past six-month firearm violence rates of 0.7, 8.9, and 34.7 percent, respectively. Trends were similar for firearm victimization and aggression. Individuals with a SaFETy score of 1 to 5 and 6+ had 7.7 and 26.2 percent higher prevalence rates of past six-month firearm violence, respectively, compared with those with a score of 0, after adjustment for age, gender, race, site, and violence-related emergency department utilization.
"This cross-sectional analysis suggests the SaFETy score may be an effective, and less intrusive, way to ascertain persons with firearm violence history," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.